These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Results of radiologic and cytostatic combination therapy in malignant diseases]. Hammer B Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442 [No Abstract] [Full Text] [Related]
9. Ectopic ACTH syndrome from bronchogenic carcinoma in association with chronic lymphocytic leukaemia. Forfar JC Postgrad Med J; 1979 Sep; 55(646):573-4. PubMed ID: 229476 [TBL] [Abstract][Full Text] [Related]
10. [Cytostatic therapy of tumors of the lung]. De Marco F; Saviano G; Tenore G Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917 [No Abstract] [Full Text] [Related]
11. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma. Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846 [No Abstract] [Full Text] [Related]
12. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease. Mountain CF Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081 [No Abstract] [Full Text] [Related]
14. The use of chemotherapy in lung cancer (controlled trials). Shnider BI Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653 [No Abstract] [Full Text] [Related]
16. Saphenous-jugular bypass as palliative therapy of superior vena cava syndrome caused by bronchial carcinoma. Vincze K; Kulka F; Csorba L J Thorac Cardiovasc Surg; 1982 Feb; 83(2):272-7. PubMed ID: 7057668 [TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Host H Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319 [No Abstract] [Full Text] [Related]